biotech / news / / Devdiscourse
BioNTech will transfer production of its COVID-19 vaccine to partner Pfizer this year.
BioNTech will close production facilities in Germany and Singapore by 2027.
KEY POINTS
- Up to 1,860 jobs at BioNTech may be affected by these site closures.
- Production of BioNTech’s COVID-19 vaccine will transfer to Pfizer this year.
- BioNTech expects to save about 500 million euros annually by 2029 from these changes.
- BioNTech plans a share buyback of up to $1 billion over the next year.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →